2. Gene
  3. BCL2 - BCL2 apoptosis regulator Gene

BCL2 - BCL2 apoptosis regulator Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

中文名称：BCL2 凋亡调节因子

种属: Sus scrofa

基因 ID: 100049703 | 基因类型: protein coding

关于 BCL2

Primary_assembly 1: 158,337,522-158,518,879 forward strand.Sscrofa11.1:CM000812.5

This gene has 1 transcript (splice variant), 230 orthologues and 8 paralogues. Ubiquitous expression in subcutaneous adipose (RPKM 3.1), ovary (RPKM 2.3) and 8 other tissues.

BCL2 基因产物(3)

mRNA Protein Name
XM_021099602.1 XP_020955261.1 apoptosis regulator Bcl-2 isoform X3
XM_021099599.1 XP_020955258.1 apoptosis regulator Bcl-2 isoform X2
XM_021099593.1 XP_020955252.1 apoptosis regulator Bcl-2 isoform X1

BCL2 蛋白结构

bcl-2

bcl-2: TIGR00865 (0 - 237)

  • 0
  • 100
  • 200
  • 238 a.a.
蛋白主名 其他名称

apoptosis regulator Bcl-2

B-cell CLL/lymphoma 2

相关产品

Approval
生物活性分子 (9)
目录号 产品名 作用方式
纯度 是否罕见病
HY-15531 Venetoclax 99.95% 是
HY-B0011 Docetaxel 99.91% 否
HY-B0318 Metronidazole 99.92% 是
HY-13407 Gossypol Antagonist 99.56% 是
HY-17510 Gossypol (acetic acid) Inhibitor 99.17% 是
HY-B0011A Docetaxel Trihydrate 99.92% 否
HY-118874 Oblimersen / 否
HY-B0318A Metronidazole hydrochloride / 否
HY-B0011R Docetaxel (Standard) / 否
Clinical Phase
生物活性分子 (16)
目录号 产品名 作用方式
纯度 Phase
HY-105930 Lobaplatin ≥98.0% Phase 4
HY-10087 Navitoclax Inhibitor 99.97% Phase 3
HY-10969 Obatoclax Mesylate 99.74% Phase 3
HY-10969A Obatoclax / Phase 3
HY-N0867 13-Oxyingenol-13-dodecanoate 99.37% Phase 3
HY-50868 Bafetinib 99.77% Phase 2
HY-109185 Pelcitoclax 99.70% Phase 2
HY-N0068 Solasodine 99.54% Phase 2
HY-129179 Lisaftoclax Inhibitor 99.28% Phase 2
HY-15464A (R)-(-)-Gossypol acetic acid 98.93% Phase 2
HY-15464 (R)-(-)-Gossypol 98.82% Phase 2
HY-138697 S65487 99.91% Phase 2
HY-138697B S65487 hydrochloride 99.67% Phase 2
HY-123823 Nitroaspirin / Phase 2
HY-138697A S65487 sulfate 98.08% Phase 2
HY-117288 S55746 Inhibitor 99.89% Phase 1
Pre-clinical Phase
生物活性分子 (190)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-50907 ABT-737 / 否
HY-107738 Guggulsterone 99.95% 否
HY-N2342 Procyanidin C1 Inducer 99.79% 否
HY-130604 DT2216 99.97% 否
HY-112416 AZD4320 Inhibitor 99.68% 否
HY-N0674 Dehydrocorydaline 99.77% 否
HY-N0087 Gambogic Acid 98.79% 否
HY-N0292 Oleuropein 99.05% 否
HY-126477 NNK 99.98% 否
HY-18628 UMI-77 Inhibitor 99.66% 否
HY-N0361 Dihydrocapsaicin 99.86% 否
HY-125877 PROTAC Mcl1 degrader-1 Inhibitor 98.13% 否
HY-103243 TCPOBOP Inhibitor 98.67% 否
HY-N3584 Paris saponin VII 99.96% 否
HY-N0265 Asperosaponin VI Inhibitor 98.91% 否
HY-118119 CAY10526 Inhibitor 99.40% 否
HY-125876 PROTAC Bcl2 degrader-1 Inhibitor 98.78% 否
HY-N2897 Dihydrokaempferol 99.88% 否
HY-148026 Sonrotoclax Inhibitor 99.51% 否
HY-15191 Sabutoclax Inhibitor 99.80% 否
HY-12020 TW-37 Inhibitor 99.27% 否
HY-15531S Venetoclax-d8 99.76% 否
HY-N0674A Dehydrocorydaline chloride 99.72% 否
HY-33350 Clofilium tosylate 99.84% 否
HY-133557 XZ739 99.06% 否
HY-139309 PROTAC Bcl-xL degrader-2 Inhibitor 98.16% 否
HY-N0674B Dehydrocorydaline (hydroxyl) 99.77% 否
HY-138832 BM-1244 Inhibitor 98.77% 否
HY-12011 HA14-1 Inhibitor ≥98.0% 否
HY-120882 BM-1197 Inhibitor 99.43% 否
HY-N3001 Isolinderalactone Inhibitor 98.79% 否
HY-129700 MCL-1/BCL-2-IN-2 Inhibitor 99.12% 否
HY-100383 BH3I-1 ≥98.0% 否
HY-10087S Navitoclax-d8 Inhibitor 99.71% 否
HY-P1889 Bim BH3, Peptide IV 99.51% 否
HY-117288A S55746 hydrochloride Inhibitor 99.66% 否
HY-142209 ABBV-167 Inhibitor 97.33% 否
HY-129681 MCL-1/BCL-2-IN-1 Inhibitor 99.86% 否
HY-16014 A-385358 Inhibitor 98.19% 否
HY-N6690 Destruxin B 99.86% 否
HY-109184 Murizatoclax Inhibitor 98.85% 否
HY-132307 Mcl-1 inhibitor 6 98.40% 否
HY-119931 2-Hydroxychalcone 98.80% 否
HY-157176 BAX-IN-1 Inhibitor ≥98.0% 否
HY-161100 BDM19 Inducer / 否
HY-N1157 Thevetiaflavone ≥98.0% 否
HY-N1440 Koumine Activator 99.97% 否
HY-N4238 Dehydrocorydaline nitrate 99.90% 否
HY-109617 4-(4-Fluorophenyl)benzoic acid 99.01% 否
HY-111329 JGB1741 99.05% 否
HY-113471A (S)-(-)-Perillic acid / 否
HY-119833 Rubone Modulator 99.1% 否
HY-13408 (+)-Apogossypol Inhibitor / 否
HY-15464D (S)-Gossypol (acetic acid) Inhibitor 98.39% 否
HY-156278 FB49 Inhibitor 99.76% 否
HY-161276 BFC1108 Inducer 98.11% 否
HY-B0011S Docetaxel-d9 ≥98.0% 否
HY-N0307 Ciwujianoside B Inhibitor 99.00% 否
HY-N2416 Taccalonolide A 99.29% 否
HY-N7930 Crenulatin ≥99.0% 否
HY-P1527 Bim BH3 / 否
HY-P2343 BH3 hydrochloride Activator 98.02% 否
HY-15191B (S)-Sabutoclax Inhibitor 98.03% 否
HY-114310 VDR agonist 1 / 否
HY-128360 dMCL1-2 Inhibitor / 否
HY-131188 PROTAC Bcl-xL degrader-1 Inhibitor / 否
HY-131247 Bcl-2-IN-2 Inhibitor / 否
HY-135273 A-1211212 / 否
HY-155188 NWP-0476 Inhibitor / 否
HY-100762 Mcl1-IN-11 Inhibitor / 否
HY-100763 Mcl1-IN-12 Inhibitor / 否
HY-146097 RMS5 / 否
HY-149918 Antiproliferative agent-23 / 否
HY-156620 Lacutoclax Inhibitor / 否
HY-19551 Apogossypolone / 否
HY-B1559 Allethrin Inducer 98.04% 否
HY-101083 BDA-366 Antagonist / 否
HY-101999 EM20-25 / 否
HY-115974 GRPR antagonist-1 Antagonist / 否
HY-118874A Oblimersen sodium Inhibitor / 否
HY-121934 BH3I-2' / 否
HY-125191 BRD1991 Inhibitor / 否
HY-127130 Spicamycin / 否
HY-129179B (Rac)-Lisaftoclax Inhibitor 97.84% 否
HY-129701 MCL-1/BCL-2-IN-3 Inhibitor 99.22% 否
HY-129702 MCL-1/BCL-2-IN-4 Inhibitor / 否
HY-133772 Venetoclax N-oxide / 否
HY-13659 KRN5500 / 否
HY-13846 BM-1074 / 否
HY-143235 BRD4 Inhibitor-15 / 否
HY-143872 Bcl-2-IN-4 Inhibitor / 否
HY-143873 Bcl-2-IN-5 Inhibitor / 否
HY-144428 Bcl-2/Mcl-1-IN-2 Inhibitor / 否
HY-144430 Bcl-2/Mcl-1-IN-1 Inhibitor / 否
HY-144431 Bcl-2/Mcl-1-IN-3 Inhibitor / 否
HY-144778 IDO1/TDO-IN-1 / 否
HY-144791 Bcl-2-IN-6 / 否
HY-144792 Bcl-2-IN-7 / 否
HY-145288 Antitumor agent-36 / 否
HY-145289 Antitumor agent-37 / 否
HY-146095 p53 Activator 2 / 否
HY-146253 CDK1/2/4-IN-1 / 否
HY-146444 Anticancer agent 56 / 否
HY-146471 EGFR-IN-51 / 否
HY-146472 EGFR-IN-52 / 否
HY-146817 Tubulin polymerization-IN-11 / 否
HY-147504 Anticancer agent 63 / 否
HY-147826 EGFR-IN-60 / 否
HY-147906 Anticancer agent 71 / 否
HY-147928 Apoptotic agent-2 / 否
HY-147929 Apoptotic agent-3 / 否
HY-149009 Bcl-2-IN-9 / 否
HY-149024 VEGFR-2-IN-23 / 否
HY-149436 CDK2/Bcl2-IN-1 Inhibitor / 否
HY-149622 Bcl-2-IN-12 Inhibitor / 否
HY-149623 Bcl-2-IN-13 Inhibitor / 否
HY-149624 Bcl-2-IN-14 / 否
HY-149625 Bcl-2-IN-15 Inhibitor / 否
HY-149681 Beclin1-Bcl-2 interaction inhibitor 1 Inhibitor / 否
HY-150540 Bcl-2-IN-10 / 否
HY-150596 CT1-3 / 否
HY-151428 Antitumor agent-78 / 否
HY-151429 Antitumor agent-77 / 否
HY-151443 HDAC-IN-47 Inhibitor / 否
HY-153494 Rosomidnar Inhibitor / 否
HY-153494A Rosomidnar sodium Inhibitor / 否
HY-153953 Bcl-2-IN-11 Inhibitor / 否
HY-155242 VEGFR-2-IN-36 / 否
HY-156096 HDAC3-IN-2 / 否
HY-156877 Bcl-2-IN-16 / 否
HY-157343 GD3 Ganglioside / 否
HY-160108 Bcl-2-IN-17 Inhibitor / 否
HY-160921 Capeserod Agonist / 否
HY-161254 ATPase-IN-3 99.89% 否
HY-161410 WH244 Degrader / 否
HY-161415 BCL-xL/BCL-2 ligand 1 / 否
HY-161577 BFC1103 / 否
HY-161659 Apoptosis inducer 19 / 否
HY-161732 GQN-B37-E Inhibitor / 否
HY-161786 Bcl-2-IN-20 / 否
HY-162148 HNPMI Inhibitor 99.57% 否
HY-163077 Anticancer agent 175 Inducer / 否
HY-163308 Bcl-2-IN-18 Inhibitor / 否
HY-163309 Bcl-2-IN-19 Inhibitor / 否
HY-163435 Anticancer agent 201 / 否
HY-163527 FGFR-IN-13 Inhibitor / 否
HY-163764 Bfl-1-IN-4 / 否
HY-18628S UMI-77-d4 Inhibitor / 否
HY-50907S ABT-737-d8 99.11% 否
HY-B0011AS Docetaxel-d5 trihydrate / 否
HY-N0361S Dihydrocapsaicin-d3 / 否
HY-N10091 2,3-Dihydro-3α-methoxynimbolide / 否
HY-N10481 Aviculin / 否
HY-N1218 Stellasterol Inhibitor / 否
HY-N1930 (-)-Hinesol Inducer / 否
HY-N2741 Vitexin B-1 Inhibitor / 否
HY-N3828 epi-Eriocalyxin A / 否
HY-N8579 Eugenyl benzoate / 否
HY-P10057 cpm-1285 Inducer / 否
HY-P10058 cpm-1285m / 否
HY-P1889A Bim BH3, Peptide IV TFA / 否
HY-P5324 Bad BH3 (mouse) / 否
HY-P5325 Bid BH3 (80-99) / 否
HY-P5327 r8 Bid BH3 / 否
HY-RS01415 BCL2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01416 Bcl2 Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01417 BCL2 Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01418 BCL2A1 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01419 Bcl2a1 Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01420 Bcl2a1a Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01421 BCL2L1 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01422 Bcl2l1 Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01423 Bcl2l1 Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01424 BCL2L10 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01425 Bcl2l10 Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01426 Bcl2l10 Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01427 BCL2L11 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01428 Bcl2l11 Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01429 Bcl2l11 Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01430 BCL2L12 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01431 BCL2L13 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01432 BCL2L14 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01433 BCL2L15 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01434 BCL2L2 Human Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01435 Bcl2l2 Mouse Pre-designed siRNA Set A Pre-designed Sets / 否
HY-RS01436 Bcl2l2 Rat Pre-designed siRNA Set A Pre-designed Sets / 否
HY-101083A (Rac)-BDA-366 Inhibitor / 否
HY-W751400 Solasodine hydrochloride / 否
HY-18106 BM 957 Inhibitor / 否
HY-P1733 BMf-BH3 / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens BCL2 NCBI NCBI:596
Mus musculus BCL2 NCBI NCBI:12043
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z